Vivet Therapeutics CEO, Jean-Philippe Combal, will be participating to 2 panels during 2019 World Orphan Drug Congress Europe in Barcelona (Nov 12-14).

The 1st panel is entitled "New models to run natural history studies and registries" (5.10pm / Wednesday 13 November, 2019). And the 2nd panel will address CMC strategies: "How can advanced therapy companies make their manufacturing process more cost effective and sustainable?" (2.10pm / Thursday 14 November, 2019).

Sonia Valero, Head of Clinical Operations & Patient Advocacy Representative at Vivet, will also be attending the conference.